Clinical Trial Update: Study of Progression to Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Incidence/Management and Treatment

View source ↗

Summary

Boehringer Ingelheim conducted a study on progression to progressive fibrosing interstitial lung disease (PF-ILD) and how it is managed and treated. The trial i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease
• Progressive Fibrosing Interstitial Lung Disease

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Lung Diseases, Interstitial | Status: COMPLETED | Results posted: 2024-09-19